Cerebrolysat (brain hydrolysate - amino acids and peptides)

1mlx10pcs or 5mlx5pcs

Cerebrolysat is a preparation of brain tissue that contains amino acids and biologically active peptides that penetrate the blood-brain barrier and directly enter the nerve cells. Cerebrolysat improves metabolic processes in brain cells, enhances protein synthesis in nerve cells, increases the brain's resistance to hypoxia, hypoglycemia, intoxication, and mechanical injuries; improves the state of regulatory mechanisms and bioelectrical activity of the brain, increases the reserve compensatory capabilities of cerebral hemodynamics. All this leads to a decrease in the severity of neurological deficits. Activates integrative processes in the central nervous system.

As part of complex therapy for cerebrovascular insufficiency (dyscirculatory encephalopathy, ischemic stroke (acute phase and rehabilitation stage), condition after hemorrhagic stroke, traumatic brain injury (concussion, traumatic brain injury, condition after brain surgery, post-traumatic asthenic syndrome ), encephalopathy of various origins), myelopathy, neuropathy, radiculopathy of various origins (infectious, toxic, traumatic), cerebral palsy, decreased concentration in children.

1 ml of the drug contains:
Active ingredient: hydrolyzed cattle brain containing amino acids and peptides; including free amino acids: L-Aspartic acid - 0.90-3.70 mg, L-Threonine - 0.70-2.10 mg, L-Serine - 0.50-2.90 mg, L-Glutamic acid - 3.75-6.25 mg, L-Proline - 0.70-1.70 mg, Glycine - 0.70-2.10 mg, L-Alanine - 1.75-5.25 mg, L-Valine - 1.35-4.05 mg, L-Methionine - 0.65-1.95 mg, L-Isoleucine - 0.90-2.30 mg, L-Leucine - 2.00-6.00 mg, L -Tyrosine - 0.13-0.63 mg, L-Phenylalanine - 0.50-1.50 mg, L-Histidine - 0.30-1.30 mg, L-Lysine - 0.95-2.85 mg , L-Arginine - 0.40-2.90 mg.
Excipient: phenol - 2.5-3.0 mg.

1-5 ml is administered intramuscularly daily or every other day. The course of treatment is 20 injections. After a 3-6 month break, treatment with Cerebrolysate can be repeated (after consultation with a doctor)
In neuropediatric practice - intramuscularly, 1-2 ml (up to 1 ml per 10 kg of body weight) for 10-15 days, repeating the course 2-3 times a year.
Contraindications
Hypersensitivity, severe renal failure, status epilepticus, pregnancy.
Carefully:
Allergic diathesis, breastfeeding period.
Use during pregnancy and breastfeeding:
Use during pregnancy is contraindicated.
If it is necessary to use it during breastfeeding, the issue of stopping breastfeeding should be decided.

Contraindications
Hypersensitivity, severe renal failure, status epilepticus, pregnancy.
Carefully:
Allergic diathesis, breastfeeding period.
Use during pregnancy and breastfeeding:
Use during pregnancy is contraindicated.
If it is necessary to use it during breastfeeding, the issue of stopping breastfeeding should be decided.